Search Within

Lisa De Angelis

  1. "Bin Gu"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (9)
  2. Surgery (7)
  3. Biostatistics Service (5)
  4. Epidemiology and Biostatistics (5)
  5. Population Sciences Research Program (5)
  6. Neuroradiology Service (4)

More Groups

People
  1. Bin Gu (9)
  2. Adilia Hormigo (8)
  3. Eric Holland (7)
  4. Martin Fleisher (7)
  5. Katherine Panageas (5)
  6. Andreas Hottinger (4)

More People

Years
  1. 2008 (2)
  2. 2007 (1)
  3. 2006 (3)
  4. 2005 (2)
  5. 2004 (1)
Publications
  1. Neuro-Oncology (5)
  2. Journal of Clinical Oncology (2)
  3. Anti-Cancer Drugs (1)
  4. Clinical Cancer Research (1)
Publishers
  1. Oxford University Press (5)
  2. American Society of Clinical Oncology (2)
  3. American Association for Cancer Research (1)
  4. Lippincott Williams & Wilkins (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A longitudinal prospective study of YKL-40 and matrix metalloproteinase-9 (MMP-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; Holland, E.; DeAngelis, L. M.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Ykl-40 and matrix metalloproteinase-9 (Mmp-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F.; Hottinger, A.; Jahdi, M.; Dantis, J.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Clarke, J.; Sul, J.; DeAngelis, L.; Lassman, A.; Hormigo, A.; Nolan, C.; Gavrilovic, I.; Gu, B.; Panageas, K.; Abrey, L.
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Matrix metalloproteinase-9 (MMP-9) as a potential serum marker for patients with primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Hottinger, A. F.; Gu, B.; Fleisher, M.; Karimi, S.; Abrey, L.; Holland, E.; Deangelis, L. M.; Hormigo, A.
    Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Prospective analysis of expression of circulating levels of matrix metalloproteinase-9 (MMP-9) in the serum of patients with primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Hottinger, A. F.; Gu, B.; Fleisher, M.; Abrey, L. E.; Holland, E.; Deangelis, L. M.; Hormigo, A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas
    Journal Article

    Hormigo, A.; Gu, B.; Karimi, S.; Riedel, E.; Panageas, K. S.; Edgar, M. A.; Tanwar, M. K.; Rao, J. S.; Fleisher, M.; Deangelis, L. M.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Prospective analysis of matrix metalloproteinase-9 (MMP-9) in the serum of patients with high-grade gliomas
    Meeting Abstract

    Hormigo, A.; Gu, B.; Riedel, E.; Rao, J.; Fleisher, M.; Panageas, K.; DeAngelis, L.; Holland, E.
    Neuro-Oncology (2005)

    Fulltext@MSK | Save
  • Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells
    Journal Article

    Gu, B.; De Angelis, L. M.
    Anti-Cancer Drugs (2005)

    Fulltext@MSK | Save
  • Prospective analysis of expression of YKL-40 in the serum of patients with glioblastoma multiforme
    Meeting Abstract

    Hormigo, A.; Gu, B.; Fleisher, M.; Deangelis, L. M.; Holland, E. C.
    Neuro-Oncology (2004)

    Fulltext@MSK | Save